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DObjective: This study examined nationwide trends in use of coronary artery bypass grafting between 1988 and
2004.
Methods: The Nationwide Inpatient Sample database was used to calculate age-adjusted rate of coronary artery
bypass grafting from 1988 to 2004. Specific International Classification of Diseases, Ninth Revision, Clinical
Modification codes for coronary artery bypass grafting were used to compile data. Patient demographic data
were also analyzed.
Results: The database recorded 1,145,285 patients older than 40 years who underwent coronary artery bypass
grafting from 1988 to 2004. Mean age was 60.21 10.55 years. Male patients underwent coronary artery bypass
grafting more than twice as frequently as female patients (70.6% vs 29.4%). From 1988, total age-adjusted rate
gradually increased for 10 years until 1997 (79.29 per 100,000 with 95% confidence interval 70.88–87.71 per
100,000 in 1988, 131.31 per 100,000 with 95% confidence interval 119.02–143.59 per 100,000 in 1997,
P< .01), with ensuing rapid decline to nearly the lowest level at end of study in 2004 (83.01 per 100,000
with 95% confidence interval 75.68–90.33 per 100,000, P< .01). Although trends were similar across ethnicity
and sex, female and ethnic minority patients had lower rates of bypass surgery than did male and white patients.
Conclusions: Use of coronary artery bypass grafting has decreased dramatically in recent years, with even lower
use among female and ethnic minority patients. This decline may be related to significant advances
in percutaneous coronary interventions and improved medical treatment of atherosclerosis in the past 10 years.
(J Thorac Cardiovasc Surg 2010;139:1545-7)Coronary artery bypass grafting (CABG) is the gold standard
for complete coronary revascularization. With recent ad-
vances in percutaneous coronary intervention (PCI) and intro-
duction of drug-eluting stents, however, many patients are
now offered PCI, with a corresponding increase in the use
ofmultivessel PCI in theUnited States in recent years.1-4 Fur-
thermore, the trends in the uses of CABG and PCI have been
influenced by such various factors as changing population,
guidelines by the expert committees and societies, upcoming
new evidence, reimbursement (Medicare andMedicaid), and
also medical profiles of patients (diabetes mellitus, single-
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The Journal of Thoracic and Carto evaluate nationwide trends in the use of CABG in the
past 15 years by means of a large inpatient database.
MATERIALS AND METHODS
Data Source
The major product of Agency for Healthcare Research and Quality’s
Healthcare Cost and Utilization Project is the National Inpatient Sample
(NIS). Researchers and policymakers use the NIS to identify, track, and
analyze national trends in health care use, access, charges, quality, and
outcomes. A 20% sample of all short-term, general, and specialty hospitals
serving adults in the United States, including federal and nonfederal institu-
tions, is approximately represented by the NIS. The NIS excludes data
elements that could directly or indirectly identify individuals. Identities of
institutions are available only in states that already make that information
public or agree to its release. For these institutions and for research purposes
only, linkage is possible to data from the Annual Survey of the American
Hospital Association’s Annual Survey Database. This sampling is done
by selecting hospitals that encompass State Inpatient Databases within sates
defined in accordance with urban or rural location, region, ownership,
number of beds, and teaching status. Selection for inclusion in NIS is based
on all discharges from the sampled hospitals for the calendar year.
Currently, NIS data are available from 1988 to 2006 from 38 states with
approximately 8 million hospital stays annually. The NIS also detains infor-
mation on primary and secondary diagnoses and procedures, discharge vital
status, and demographic data on more than 7 million discharges per year.
Association of discharge data and NIS data set with hospital characteristics
can be made available by a unique hospital identifier.
Sample Selection
From the NIS database, we obtained specific International Classification
of Diseases, Ninth Revision, Clinical Modification codes for CABG todiovascular Surgery c Volume 139, Number 6 1545
FIGURE 1. Age-adjusted coronary artery bypass grafting procedures per
100,000 for total and by sex.
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
NIS ¼ National Inpatient Sample
PCI ¼ percutaneous coronary intervention
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Dcompile the data.We used the primary code for CABG from 1988 to 2004 as
follows: 36.10, 36.11, 36.12, 36.13, 36.14, 36.15, 36.16, 36.17, and 36.19.
To exclude nonatherosclerotic causes of coronary disease, we limited data to
patients older than 40 years. Furthermore, we obtained demographic infor-
mation such as sex, ethnic groups, and age per 100,000 for this period and
calculated the age-adjusted rates for sex and ethnic groups.
Statistical Analysis
The average annual age-adjusted CABG rates were calculated along
95% confidence intervals (CIs) for each year for the entire cohort and by
sex and ethnic groups by weighted average of the age-specific (crude) rates,
where the weights were the proportions of persons in the corresponding age
groups of a standard population. The weights used in the age-adjustment of
the data were the proportions of the year 2000 standard US population
within each age group. The weighted rates were then summed across the
age groups to give the age-adjusted rate for each year from 1998 to 2004.
Statistical Package for the Social Sciences (SPSS Inc, Chicago, Ill) and
SAS (SAS Institute, Inc, Cary, NC) software packages were used to
calculate age-adjusted rate.13 Quantitative variables were expressed as
mean  SD. Independent samples t test was used for comparison.RESULTS
The NIS database contained 1,145,285 patients who had
CABG performed from 1988 to 2004. The mean age for
these patients was 60.21  10.55 years. Of this patient
cohort, 70.6% were male and 29.4% female. From 1988,
the age-adjusted rate for all CABG gradually increased for
10 years until 1997 (79.29 per 100.000 with 95% CI
70.88–87.71 per 100,000 in 1988 and 131.31 per 100.000
with 95% CI 119.02–143.59 per 100,000, P < .01) in
1997), with an ensuing rapid decline to almost the lowest
level at the end of the study in 2004 (83.01 per 100.000
with 95% CI 75.68–90.33 per 100,000, P< .01 in 2004;
Figure 1). Trends were similar by sex and across different
ethnic groups (Figures 1 and 2).FIGURE 2. Age-adjusted coronary artery bypass grafting proced
1546 The Journal of Thoracic and Cardiovascular SurDISCUSSION
We found that the use of CABG in the United States has
been decreasing steadily during recent years. This declining
trend has been reported previously, confirming our finding.
In the Mayo Clinic registry, CABG rate decline occurred
after 1988.8 This decline has also been documented for
isolated CABG procedures done on an emergency basis after
PCI.9
The decline in the use of CABG can be attributed to
various causes. CABG as the main route for complete revas-
cularization has been increasingly replaced by PCI in
response to advances in PCI techniques and the introduction
of drug-eluting stents, which have dramatically reduced the
rate of in-stent restenosis. We recently documented increas-
ing use of multivessel PCI in the United States, confirming
this upward trend.2 Most trials have documented higher
revascularization rates in multivessel disease with PCI
than with CABG.10 Mortality has been the same, however,
except for patients with diabetes.11,12 A recently published
randomized multicenter SYNTAX trial10 confirmed previ-
ous studies13,14 by showing that PCI is not inferior to
CABG in regard to mortality for patients with left main or
3-vessel coronary artery diseases who are suitable
candidates for both interventions.
These trials have led to increasing use of PCI relative to
CABG in many experienced centers, explaining our find-
ings. A study on 5.4 million Medicare beneficiaries showed
that the rates of PCI were much higher than the rates of
CABG for all groups but were proportionately even higherures per 100,000 by ethnic group. Pac Isl, Pacific Islanders.
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Dfor older patients, women, and black patients.15 In addition
to increasing PCI use as a main contributor to the decline
in the rate of CABG procedures, increasing use of aggressive
medical therapy, such as lipid-lowering medications,
b-blockers, and angiotensin-converting enzyme inhibitors,
has been thought to be related to a significant decline in
the incidence of atherosclerosis and myocardial infarction,
which in turn has probably contributed to the lower rate of
CABG in recent years. Furthermore, we found that female
and ethnic minority patients were less likely to undergo
CABG than were male or white patients and that the rate
of decline in CABG prevalence was lower among African
American patients than among other ethnic groups. This
sex- and ethnicity-based disparity is in concordance with
published literature documenting lower rates of CABG or in-
vasive procedures among patients of minority ethnic groups
and among women.16-21 The causes of this sex and ethnic
disparity in the use of CABG and of the slower decline in
the use of CABG among African Americans are not known.
There are many theories to explain this disparity. Some
blame lower insurance coverage or lower access to hospital
services.19,22 Others have found clinical and nonclinical fac-
tors that appear to account for some of this disparity.21,23,24
Further research is needed to elaborate ethnic and sex differ-
ences in the use of invasive procedures.Limitations
This study has limitations inherent in the database used.
The data were obtained from 1045 hospitals in 38 states,
approximating only 20% of US community hospitals.
Another limitation of this study is the fact that NIS data
use International Classification of Diseases, Ninth Revision,
Clinical Modification codes, which represent administrative
coding with arguable clinical accuracy.CONCLUSIONS
Our study demonstrated in a large patient population that
the use of CABG has dramatically decreased to almost its
lowest level after 1997. We believe that this finding may
reflect significant advances in PCI, increased experience of
operators, and aggressive treatment of atherosclerosis in
recent years.References
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